BACKGROUND: Hepatitis B virus (HBV) preS mutations are frequently isolated from patients with severe forms of liver disease. Meanwhile, genotype C has been shown to cause more serious liver disease than genotype B. This study assesses the frequency of preS mutation in Chinese patients with genotype C chronic HBV infection and its relation to liver damage. METHODS: Seventy-nine persistently infected patients (25 asymptomatic carriers, 28 with chronic hepatitis, and 26 with hepatocellular carcinoma) with genotype C HBV were analyzed. Levels of HBV DNA, hepatitis B e antigen (HBeAg), alanine aminotransferase, and aspartate transaminase and mutations in the preS region were determined. RESULTS: The correlations of preS deletion with disease progression were distinct: preS deletion mutations were more commonly found in the hepatocellular carcinoma (HCC) group than in the chronic hepatitis B (CHB) or asymptomatic carrier (ASC) groups, with the frequencies of 38.46% (10/26) in the HCC, 7.14% (2/28) in the CHB, and 4.00% (1/25) in the ASC (P = 0.001) groups. The HBeAg-positive rate and HBV DNA levels were comparable between patients with the preS mutation and those without. CONCLUSIONS: PreS deletion mutations of genotype C HBV might play a role in HBV-related hepatocarcinogenesis.
BACKGROUND: Hepatitis B virus (HBV) preS mutations are frequently isolated from patients with severe forms of liver disease. Meanwhile, genotype C has been shown to cause more serious liver disease than genotype B. This study assesses the frequency of preS mutation in Chinese patients with genotype C chronic HBV infection and its relation to liver damage. METHODS: Seventy-nine persistently infected patients (25 asymptomatic carriers, 28 with chronic hepatitis, and 26 with hepatocellular carcinoma) with genotype C HBV were analyzed. Levels of HBV DNA, hepatitis B e antigen (HBeAg), alanine aminotransferase, and aspartate transaminase and mutations in the preS region were determined. RESULTS: The correlations of preS deletion with disease progression were distinct: preS deletion mutations were more commonly found in the hepatocellular carcinoma (HCC) group than in the chronic hepatitis B (CHB) or asymptomatic carrier (ASC) groups, with the frequencies of 38.46% (10/26) in the HCC, 7.14% (2/28) in the CHB, and 4.00% (1/25) in the ASC (P = 0.001) groups. The HBeAg-positive rate and HBV DNA levels were comparable between patients with the preS mutation and those without. CONCLUSIONS: PreS deletion mutations of genotype C HBV might play a role in HBV-related hepatocarcinogenesis.
Authors: T Santantonio; M C Jung; R Schneider; D Fernholz; M Milella; L Monno; G Pastore; G R Pape; H Will Journal: Virology Date: 1992-06 Impact factor: 3.616
Authors: M Sterneck; T Kalinina; S Otto; S Günther; L Fischer; M Burdelski; H Greten; C E Broelsch; H Will Journal: J Infect Dis Date: 1998-05 Impact factor: 5.226
Authors: Chi-Jen Chu; Emmet B Keeffe; Steven-Huy Han; Robert P Perrillo; Albert D Min; Consuelo Soldevila-Pico; William Carey; Robert S Brown; Velimir A Luketic; Norah Terrault; Anna S F Lok Journal: Gastroenterology Date: 2003-08 Impact factor: 22.682
Authors: Jia-Xin Xie; Jun Zhao; Jian-Hua Yin; Qi Zhang; Rui Pu; Wen-Ying Lu; Hong-Wei Zhang; Hong-Yang Wang; Guang-Wen Cao Journal: Front Med China Date: 2010-11-19
Authors: Nicola Coppola; Lorenzo Onorato; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Caterina Sagnelli; Evangelista Sagnelli Journal: World J Hepatol Date: 2015-11-28
Authors: B D Betz-Stablein; A Töpfer; M Littlejohn; L Yuen; D Colledge; V Sozzi; P Angus; A Thompson; P Revill; N Beerenwinkel; N Warner; F Luciani Journal: J Virol Date: 2016-07-27 Impact factor: 5.103